Literature DB >> 9180310

Middle-term results of threaded acetabular cups. High failure rates five years after surgery.

H G Simank1, D R Brocai, D Reiser, M Thomsen, D Sabo, M Lukoschek.   

Abstract

We report our results using three different threaded acetabular components (Mecring A, Mecring B and Weill) in 715 hips with a follow-up of between one and ten years (median: 99.1, 56.5, 38.3 months, respectively). All cups were implanted with one type of cementless stem. The clinical results were good or acceptable in about 70% of the hips, but signs of loosening with radiolucency and/or migration were found in 10.1%. Radiological evidence of loosening did not correlate significantly with the clinical outcome. Pain was not a reliable indicator of loosening and its absence sometimes allowed severe osteolysis to develop. Twenty-five hips were revised (3.5%) for aseptic loosening of the acetabular component. Kaplan-Meier estimates of the cumulative rate of failure showed a rapid increase five years after the initial operation, but no significant correlation with gender, age or weight. The high rate of failure indicates that further use of these acetabular components cannot be recommended. Annual radiographs are required to assess osteolysis even if the patients are free from pain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180310     DOI: 10.1302/0301-620x.79b3.7273

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  11 in total

1.  Current attitudes to total hip replacement in the younger patient: results of a national survey.

Authors:  T D Tennent; N J Goddard
Journal:  Ann R Coll Surg Engl       Date:  2000-01       Impact factor: 1.891

2.  Survival of the cementless Spotorno stem in the second decade.

Authors:  Peter R Aldinger; Alexander W Jung; Steffen J Breusch; Volker Ewerbeck; Dominik Parsch
Journal:  Clin Orthop Relat Res       Date:  2009-06-06       Impact factor: 4.176

3.  Multicentre use of a porous tantalum monoblock acetabular component.

Authors:  Th A Xenakis; G A Macheras; K S Stafilas; A T Kostakos; K Bargiotas; K N Malizos
Journal:  Int Orthop       Date:  2008-05-29       Impact factor: 3.075

4.  [Five-year survival rate of the Allofit titanium press-fit cup].

Authors:  K Schroeder; A Moehlenbruch; M Zimmermann-Stenzel; D Parsch
Journal:  Orthopade       Date:  2010-01       Impact factor: 1.087

5.  Bone remodeling around stable uncemented titanium stems during the second decade after total hip arthroplasty: a DXA study at 12 and 17 years.

Authors:  C Merle; M R Streit; C Volz; M Pritsch; T Gotterbarm; P R Aldinger
Journal:  Osteoporos Int       Date:  2010-11-23       Impact factor: 4.507

6.  Long-term results of the threaded Mecron cup in primary total hip arthroplasty : A 15-20-year follow-up study.

Authors:  Michael Clarius; Alexander W Jung; Marcus R Streit; Christian Merle; Patric Raiss; Peter R Aldinger
Journal:  Int Orthop       Date:  2009-07-24       Impact factor: 3.075

7.  Long-term results of the threaded Weill cup in primary total hip arthroplasty: a 15-20-year follow-up study.

Authors:  Michael Clarius; Alexander W Jung; Patric Raiss; Marcus R Streit; Christian Merle; Peter R Aldinger
Journal:  Int Orthop       Date:  2009-07-24       Impact factor: 3.075

8.  [Metal sensitivity in patients with joint replacement arthroplasties before and after surgery].

Authors:  C Rau; P Thomas; M Thomsen
Journal:  Orthopade       Date:  2008-02       Impact factor: 1.087

9.  Results of 3,668 primary total hip replacements for primary osteoarthritis in patients under the age of 55 years.

Authors:  Keijo T Mäkelä; Antti Eskelinen; Pekka Pulkkinen; Pekka Paavolainen; Ville Remes
Journal:  Acta Orthop       Date:  2011-10       Impact factor: 3.717

10.  Failure of Polyethylene Inlays in Cementless Total Hip Arthroplasty: A Retrieval Analysis.

Authors:  Ulrike Mueller; Christoph Lee; Christian Heisel; Marc Thomsen; Rudi G Bitsch; J Philippe Kretzer
Journal:  Biomed Res Int       Date:  2016-08-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.